Press release
September 8, 2026
Spruce Biosciences to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Spruce Biosciences, Inc. (SPRB)
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 8, 2026-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier